Document is current

Any future updates will be listed below

Efficacy and treatment-related adverse events of multi-targeted tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s11096-022-01465-w

Published Online: 2022-08-11

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark